Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258271
Status:
COMPLETED
Last Update Posted:
2013-10-16
First Post:
2005-11-22
Brief Title:
Cladribine Cytarabine and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Sponsor:
University of Rochester
Organization:
University of Rochester
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| recurrent adult acute myeloid leukemia | View |
| adult acute basophilic leukemia | View |
| adult acute eosinophilic leukemia | View |
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute monoblastic leukemia M5a | View |
| adult acute monocytic leukemia M5b | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult erythroleukemia M6a | View |
| adult pure erythroid leukemia M6b | View |
| blastic phase chronic myelogenous leukemia | View |
| relapsing chronic myelogenous leukemia | View |